EN
抗体药类似物
Research Grade Blosozumab
All
TD-HV185026_1.jpg
TD-HV185026_2.jpg
TD-HV185026_3.jpg
  • CatalogTD-HV185026
  • ClonalitymAb
  • Application Research Grade Biosimilar
  • SynonymsLY2541546,CAS:1132758-87-2
  • 规格
    1mg
  • 价格
    ¥询价
定制服务咨询

Research Grade Blosozumab


Catalog No. TD-HV185026
Species reactivity Human
Applications Research Grade Biosimilar
Host species Humanized
Isotype IgG4-kappa
Expression system Mammalian Cells
Clonality Monoclonal
Target SOST, Sclerostin
Endotoxin level Please contact the lab for this information.
Purity >95% purity as determined by SDS-PAGE.
Purification Protein A/G, purified from cell culture supernatant.
Accession Q9BQB4
Form Liquid
Storage buffer 0.01M PBS,pH7.4.
Stability and Storage Use a manual defrost freezer and avoid repeated freeze-thaw cycles. Store at 4°C for short-term storage (1-2 weeks). Store at -20°C for up to 12 months. For long-term storage, store at -80°C.
Alternate Names LY2541546,CAS:1132758-87-2
Background Blosozumab (LY2541546) is an anti-Human sclerostin (SOST) antibody inhibitor. Blosozumab stimulates bone formation and reduces bone resorption. Blosozumab can be used in the research of Osteoporosis.
Note For research use only. Not for use in clinical or therapeutic applications.

 

TD-HV185026_1.jpg
SEC-HPLC
 
SEC-HPLC detection for Research Grade Blosozumab.
TD-HV185026_2.jpg
Bioactivity
 
Detects Human SOST in indirect ELISAs.
TD-HV185026_3.jpg
SDS-PAGE
 
SDS-PAGE for Research Grade Blosozumab.